Cargando…

DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy

DNA methyltransferases are an essential class of modifiers in epigenetics. In mammals, DNMT1, DNMT3A and DNMT3B participate in DNA methylation to regulate normal biological functions, such as embryo development, cell differentiation and gene transcription. Aberrant functions of DNMTs are frequently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jiayu, Yang, Cheng, Wu, Chunfu, Cui, Wei, Wang, Lihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465608/ https://www.ncbi.nlm.nih.gov/pubmed/32751889 http://dx.doi.org/10.3390/cancers12082123

Ejemplares similares

Histone methyltransferase and drug resistance in cancers
por: Yang, Cheng, et al.
Publicado: (2020)

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
por: Qi, Ya-Nan, et al.
Publicado: (2023)

Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
por: Gao, Jun, et al.
Publicado: (2013)

Inhibition of DNA methyltransferase aberrations reinstates antioxidant aging suppressors and ameliorates renal aging
por: Gao, Qi, et al.
Publicado: (2021)

Protein arginine methyltransferases: promising targets for cancer therapy
por: Hwang, Jee Won, et al.
Publicado: (2021)

DNA Methyltransferases: A Novel Target for Prevention and Therapy
por: Subramaniam, Dharmalingam, et al.
Publicado: (2014)

Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
por: Morera, Ludovica, et al.
Publicado: (2016)

DNA methyltransferases and their roles in tumorigenesis
por: Zhang, Wu, et al.
Publicado: (2017)

DNA Methyltransferases, DNA Methylation, and Age-Associated Cognitive Function
por: Cui, Di, et al.
Publicado: (2018)

DNA methylation and DNA methyltransferases
por: Edwards, John R., et al.
Publicado: (2017)

Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox
por: Yu, Ke‐Da, et al.
Publicado: (2021)

Small RNA-mediated DNA (cytosine-5) methyltransferase 1 inhibition leads to aberrant DNA methylation
por: Zhang, Guoqiang, et al.
Publicado: (2015)

Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
por: Jeusset, Lucile M-P, et al.
Publicado: (2019)

A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis
por: Zhou, Qianqian, et al.
Publicado: (2023)

Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases
por: Miyagawa, Fumi
Publicado: (2022)

Aberrant Activity of Histone–Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis
por: Poreba, Elzbieta, et al.
Publicado: (2020)

Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer
por: Ding, Jiayu, et al.
Publicado: (2022)

Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
por: Castelli, Germana, et al.
Publicado: (2017)

DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
por: Hu, Chunhong, et al.
Publicado: (2021)

Misregulation of the expression and activity of DNA methyltransferases in cancer
por: Mensah, Isaiah K, et al.
Publicado: (2021)

Epigenetic synthetic lethality approaches in cancer therapy
por: Yang, Haoshen, et al.
Publicado: (2019)

Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy
por: Hamamoto, Ryuji, et al.
Publicado: (2016)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
por: Degirmenci, Ufuk, et al.
Publicado: (2020)

Identification of preferential target sites for human DNA methyltransferases
por: Choi, Si Ho, et al.
Publicado: (2011)

Mechanisms of DNA Methyltransferase Recruitment in Mammals
por: Laisné, Marthe, et al.
Publicado: (2018)

Chemical Biology of Protein N‐Terminal Methyltransferases
por: Huang, Rong
Publicado: (2019)

Biological functions of m(6)A methyltransferases
por: Gu, Jianzhong, et al.
Publicado: (2021)

Catechol-O-methyltransferase, a new target for pancreatic cancer therapy
por: Wu, Wenming, et al.
Publicado: (2015)

Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer
por: Lin, Ruo-Kai, et al.
Publicado: (2014)

Phosphatidylethanolamine N-methyltransferase: from Functions to Diseases
por: Li, Jiayu, et al.
Publicado: (2023)

Aberrant DNA Methylation of ABC Transporters in Cancer
por: Zappe, Katja, et al.
Publicado: (2020)

Heterodimeric DNA methyltransferases as a platform for creating designer zinc finger methyltransferases for targeted DNA methylation in cells
por: Meister, Glenna E., et al.
Publicado: (2010)

The Role of Paxillin Aberrant Expression in Cancer and Its Potential as a Target for Cancer Therapy
por: Liu, Weixian, et al.
Publicado: (2023)

Aberrant DNA methylation in cervical Carcinogenesis
por: Yang, Hui-Juan
Publicado: (2013)

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
por: Gravina, Giovanni L, et al.
Publicado: (2010)

Regulation of neuronal survival by DNA methyltransferases
por: Symmank, Judit, et al.
Publicado: (2017)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
por: Tse, Brian W. C., et al.
Publicado: (2012)

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
por: Nakaoka, Toshiaki, et al.
Publicado: (2017)

Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

DNA Methyltransferase Activity Assays: Advances and Challenges
por: Poh, Wan Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k34o9kd42kkq2nkroc9uo0g6ri